| Primary |
|
|
| Secondary |
| Hypertension |
43.6% |
| Product Used For Unknown Indication |
19.1% |
| Drug Use For Unknown Indication |
13.8% |
| Prophylaxis Against Transplant Rejection |
4.3% |
| Hypercholesterolaemia |
3.2% |
| Blood Cholesterol Increased |
2.1% |
| Erysipelas |
2.1% |
| Essential Hypertension |
2.1% |
| Prophylaxis |
2.1% |
| Venous Insufficiency |
2.1% |
| Benign Prostatic Hyperplasia |
1.1% |
| Depression |
1.1% |
| Diabetes Mellitus |
1.1% |
| Hypokalaemia |
1.1% |
| Sleep Disorder |
1.1% |
|
| Oedema Peripheral |
18.5% |
| Vomiting |
14.8% |
| Headache |
7.4% |
| Throat Irritation |
7.4% |
| Toxic Skin Eruption |
7.4% |
| Eosinophilic Pneumonia |
3.7% |
| Fall |
3.7% |
| Hypertension |
3.7% |
| Pemphigoid |
3.7% |
| Pulmonary Arterial Hypertension |
3.7% |
| Pulmonary Embolism |
3.7% |
| Renal Failure |
3.7% |
| Renal Failure Acute |
3.7% |
| Somnambulism |
3.7% |
| Thrombophlebitis |
3.7% |
| Venoocclusive Disease |
3.7% |
| Ventricular Extrasystoles |
3.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.5% |
| Hypertension |
22.3% |
| Product Used For Unknown Indication |
20.7% |
| Rheumatoid Arthritis |
4.6% |
| Type 2 Diabetes Mellitus |
4.6% |
| B-cell Lymphoma |
3.1% |
| Diabetes Mellitus |
2.4% |
| Prophylaxis |
2.0% |
| Cardiac Failure |
1.7% |
| Coronary Artery Disease |
1.7% |
| Osteoporosis |
1.7% |
| Atrial Fibrillation |
1.5% |
| Hypercholesterolaemia |
1.5% |
| Pain |
1.5% |
| Depression |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Hypothyroidism |
1.2% |
| Thrombosis Prophylaxis |
1.2% |
| Diabetes Mellitus Inadequate Control |
1.0% |
| Dyslipidaemia |
1.0% |
|
| Renal Failure Acute |
7.4% |
| Vomiting |
7.4% |
| Malaise |
6.2% |
| Rhabdomyolysis |
6.2% |
| White Blood Cell Count Increased |
6.2% |
| Circulatory Collapse |
4.9% |
| Diabetic Nephropathy |
4.9% |
| Hyponatraemia |
4.9% |
| Paraesthesia |
4.9% |
| Pneumonia |
4.9% |
| Pruritus |
4.9% |
| Pulmonary Embolism |
4.9% |
| Renal Failure |
4.9% |
| Weight Decreased |
4.9% |
| Gastroenteritis |
3.7% |
| Guillain-barre Syndrome |
3.7% |
| Hypertensive Crisis |
3.7% |
| Inappropriate Antidiuretic Hormone Secretion |
3.7% |
| Pain |
3.7% |
| Palpitations |
3.7% |
|
| Interacting |
| Product Used For Unknown Indication |
66.7% |
| Hiv Infection |
16.7% |
| Hypertension |
5.6% |
| Lower Respiratory Tract Infection |
5.6% |
| Supraventricular Tachycardia |
5.6% |
|
| Drug Interaction |
33.3% |
| Hypotension |
33.3% |
| Renal Impairment |
33.3% |
|
